NOVIGENIX Company
Novigenix is a precision medicine company that specializes in ImmunoTranscriptomic solutions.
Technology:
Immunotherapy
Industry:
AI
Headquarters:
Epalinges, Vaud, Switzerland
Founded Date:
01.01.2014
Employees Number:
11-50
Funding Status:
Early Stage Venture
Investors Number:
1
Total Funding:
21108513
Estimated Revenue:
$1M to $10M
Last Funding Date:
15.11.2022
Last Funding Type:
Series B
Register and Claim Ownership